GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
21 Dec 2022 03:30 PM
RNS
Director/PDMR Shareholding
15 Dec 2022 03:30 PM
RNS
Board and Committee Changes
13 Dec 2022 03:30 PM
RNS
Director/PDMR Shareholding
07 Dec 2022 07:00 AM
RNS
Statement: Zantac (ranitidine) litigation
05 Dec 2022 04:00 PM
RNS
Transfer of Treasury Shares
02 Dec 2022 03:30 PM
RNS
Director/PDMR Shareholding
02 Dec 2022 07:00 AM
RNS
EMA file accepted for momelotinib
02 Dec 2022 07:00 AM
RNS
Jemperli positive trial in endometrial cancer
01 Dec 2022 03:00 PM
RNS
Total Voting Rights
24 Nov 2022 03:00 PM
RNS
GSK publishes provisional 2023 dividend dates
22 Nov 2022 07:00 AM
RNS
Blenrep US Update
21 Nov 2022 03:30 PM
RNS
Director/PDMR Shareholding
15 Nov 2022 04:00 PM
RNS
Block listing Interim Review
11 Nov 2022 07:00 AM
RNS
GSK Update: Zejula 2L in US
10 Nov 2022 06:10 PM
RNS
Sanofi-GSK COVID booster vaccine approved by EU
10 Nov 2022 03:30 PM
RNS
Director/PDMR Shareholding
10 Nov 2022 09:00 AM
RNS
Block Listing Application
07 Nov 2022 07:00 AM
RNS
DREAMM-3 phase III trial for Blenrep
03 Nov 2022 07:00 AM
RNS
IDMC recommends gepotidacin early efficacy stop
02 Nov 2022 07:01 AM
RNS
3rd Quarter Results
02 Nov 2022 07:00 AM
RNS
GSK RSV vaccine: US FDA Priority Review
01 Nov 2022 03:00 PM
RNS
Total Voting Rights
28 Oct 2022 07:00 AM
RNS
EMA accepts GSK RSV older adult vaccine for review
28 Oct 2022 07:00 AM
RNS
EMA validates MAA for cabotegravir LA for PrEP
27 Oct 2022 07:05 AM
RNS
GSK announces FDA meeting outcome on daprodustat
27 Oct 2022 07:00 AM
RNS
ContRAst phase III programme for otilimab update
25 Oct 2022 10:00 AM
RNS
Board Committee Changes
21 Oct 2022 07:00 AM
RNS
RSV older adult vaccine submission in Japan
17 Oct 2022 07:00 AM
RNS
Menveo new single-vial approved by US FDA
14 Oct 2022 02:11 PM
RNS
Director/PDMR Shareholding
13 Oct 2022 12:46 PM
RNS
Director/PDMR Shareholding
13 Oct 2022 09:44 AM
RNS
Director/PDMR Shareholding
13 Oct 2022 08:26 AM
RNS
Director/PDMR Shareholding
13 Oct 2022 07:00 AM
RNS
Efficacy results for GSK's older adult RSV vaccine
12 Oct 2022 11:42 AM
RNS
Director/PDMR Shareholding
10 Oct 2022 07:00 AM
RNS
US FDA approves Boostrix maternal immunisation
07 Oct 2022 04:38 PM
RNS
Director/PDMR Shareholding
07 Oct 2022 04:24 PM
RNS
Director/PDMR Shareholding
03 Oct 2022 10:10 AM
RNS
Total Voting Rights
30 Sep 2022 05:21 PM
RNS
Director/PDMR Shareholding
26 Sep 2022 05:09 PM
RNS
Director/PDMR Shareholding
26 Sep 2022 07:00 AM
RNS
GSK Chief Financial Officer succession
22 Sep 2022 02:00 PM
RNS
US FDA ODAC review of Zejula Phase III NOVA trial
22 Sep 2022 07:00 AM
RNS
GSK and Spero Therapeutics licence for tebipenem
21 Sep 2022 11:22 AM
RNS
Director/PDMR Shareholding
13 Sep 2022 09:11 AM
RNS
Director/PDMR Shareholding
08 Sep 2022 12:58 PM
RNS
Director/PDMR Shareholding
06 Sep 2022 01:00 PM
RNS
GSK provides update on FDA review of daprodustat
01 Sep 2022 11:48 AM
RNS
Total Voting Rights
24 Aug 2022 07:00 AM
RNS
GSK Board changes

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

UK 100

Latest directors dealings